German pharmaceutical giant Merck has announced an agreement to acquire U.S.-based biotechnology company Bio-Techne in a deal valued at approximately $11.3 billion, marking one of the largest life sciences acquisitions of the year. The transaction reflects the growing race among global healthcare companies to strengthen their positions in biotechnology, diagnostics, and advanced research tools. As
Related Articles
Don't miss out on breaking stories and in-depth articles.